Evidence-based review of pharmacologic and nonpharmacologic treatments for older adults with schizophrenia

Psychiatric Clinics of North America

Volumn 28, Issue 4, 2005, Pages 913-939

  Van Citters, Aricca D ^a   Pratt, Sarah I ^a   Bartels, Stephen J ^a   Jeste, Dilip V ^b  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CHLORAL HYDRATE; CHLORPROMAZINE; CLOZAPINE; DONEPEZIL; FLUPHENAZINE; HALOPERIDOL; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; RIVASTIGMINE; THIORIDAZINE; TRAZODONE;

ABSENCE OF SIDE EFFECTS; BEHAVIOR THERAPY; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; GERIATRIC DISORDER; HUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

AGED; ANTIPSYCHOTIC AGENTS; HUMANS; PSYCHOTHERAPY; SCHIZOPHRENIA;

EID: 28544443793     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2005.08.001     Document Type: Review

References (84)

1. D.V. Jeste, E.W. Twamley, and L.T. Eyler Zorrilla Aging and outcome in schizophrenia Acta Psychiatr Scand 107 5 2003 336 343
2. M.J. Harris, and D.V. Jeste Late-onset schizophrenia: an overview Schizophr Bull 14 1 1988 39 55
3. S.J. Bartels, K.T. Mueser, and K.M. Miles Functional impairments in elderly patients with schizophrenia and major affective illness in the community: social skills, living skills, and behavior problems Behav Ther 28 1 1997 43 63
4. S.J. Bartels Caring for the whole person: integrated health care for older adults with severe mental illness and medical comorbidity J Am Geriatr Soc 52 12 2004 S249 S257
5. D.V. Jeste, J.A. Gladsjo, and L.A. Lindamer Medical comorbidity in schizophrenia Schizophr Bull 22 3 1996 413 430
6. S.J. Bartels, R.E. Clark, and W.J. Peacock Medicare and Medicaid costs for schizophrenia patients by age cohort compared with depression, dementia, and medically ill patients Am J Geriatr Psychiatry 11 6 2003 648 657
7. United States Census Bureau. US interim projections by age, sex, race, and Hispanic origin: table 2a. projected population of the united states, by age and sex: 2000 to 2050. Aug 26, 2004. Available at: http://www.census.gov/ipc/ www/usinterimproj/. Accessed May 16, 2005.
8. D.V. Jeste, G.S. Alexopoulos, and S.J. Bartels Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades Arch Gen Psychiatry 56 9 1999 848 853
9. W.E. Narrow, D.S. Rae, and L.N. Robins Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 survey's estimates Arch Gen Psychiatry 59 2 2002 115 123
10. A.F. Lehman, R.W. Buchanan, and F.B. Dickerson Evidence-based treatment for schizophrenia Psychiatr Clin North Am 26 4 2003 939 954
11. M. Camprubi, and L. Dratcu Evidence-based management of schizophrenia Hosp Med 65 4 2004 201 205
12. R. Emsley, and P. Oosthuizen Evidence-based pharmacotherapy of schizophrenia Int J Neuropsychopharmacol 7 2 2004 219 238
13. F. Margison Evidence-based medicine in the psychological treatment of schizophrenia J Am Acad Psychoanal Dyn Psychiatry 31 1 2003 177 190
14. R.E. Drake, K.T. Mueser, and W.C. Torrey Evidence-based treatment of schizophrenia Curr Psychiatry Rep 2 5 2000 393 397
15. S. Arunpongpaisal, I. Ahmed, and N. Aqeel Antipsychotic drug treatment for elderly people with late-onset schizophrenia Cochrane Database Syst Rev 2 2003 CD004162
16. A.L. Phanjoo, and C. Link Remoxipride versus thioridazine in elderly psychotic patients Acta Psychiatr Scand 82 Suppl 358 1990 S181 S185
17. L.E. Tune, and C. Salzman Schizophrenia in late life Psychiatr Clin North Am 26 1 2003 103 113
18. J.A. Sable, and D.V. Jeste Antipsychotic treatment for late-life schizophrenia Curr Psychiatry Rep 4 4 2002 299 306
19. C. Salzman, and L. Tune Neuroleptic treatment of late-life schizophrenia Harv Rev Psychiatry 9 2 2001 77 83
20. S. Banerjee, and E. Dickinson Evidence based health care in old age psychiatry Int J Psychiatry Med 27 3 1997 283 292
21. D.V. Jeste, E. Rockwell, and M.J. Harris Conventional vs. newer antipsychotics in elderly patients Am J Geriatr Psychiatry 7 1 1999 70 76
22. M.H. Branchey, J.H. Lee, and R. Amin High- and low-potency neuroleptics in elderly psychiatric patients JAMA 239 18 1978 1860 1862
23. P.E. Ruskin, and G. Nyman Discontinuation of neuroleptic medication in older, outpatient schizophrenics: a placebo-controlled, double-blind trial J Nerv Ment Dis 179 4 1991 212 214
24. E. Howanitz, M. Pardo, and D.A. Smelson The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia J Clin Psychiatry 60 1 1999 41 44
25. J.S. Kennedy, D. Jeste, and C.J. Kaiser Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial Int J Geriatr Psychiatry 18 11 2003 1013 1020
26. D.V. Jeste, Y. Barak, S. Madhusoodanan, and F. Grossman International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia Am J Geriatr Psychiatry 11 6 2003 638 647 [erratum appears in: Am J Geriatr Psychiatry. 2004;12(1):49]
27. P.D. Harvey, J.A. Napolitano, and L. Mao Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder Int J Geriatr Psychiatry 18 9 2003 820 829
28. Y. Barak, E. Shamir, and H. Zemishlani Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients Prog Neuropsychopharmacol Biol Psychiatry 26 6 2002 1199 1202
29. C.W. Ritchie, E. Chiu, and S. Harrigan The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia Int J Geriatr Psychiatry 18 5 2003 432 440
30. Y. Barak, E. Shamir, and R. Weizman Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? a naturalistic, long-term, retrospective, comparative study J Clin Psychopharmacol 22 2 2002 115 120
31. A. Ciudad, J.M. Montes, and J.M. Olivares Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic study Eur Psychiatry 19 6 2004 358 365
32. S. Madhusoodanan, M. Brecher, and R. Brenner Risperidone in the treatment of elderly patients with psychotic disorders Am J Geriatr Psychiatry 7 2 1999 132 138
33. M. Davidson, P.D. Harvey, J. Vervarcke on behalf of the Risperidone Working Group A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis Int J Geriatr Psychiatry 15 6 2000 506 514
34. T. Hayashi, N. Yokota, and T. Takahashi Benefits of trazodone and mianserin for patients with late-life chronic schizophrenia and tardive dyskinesia: an add-on, double-blind, placebo-controlled study Int Clin Psychopharmacol 12 4 1997 199 205
35. J.W. Kasckow, S. Mohamed, and A. Thallasinos Citalopram augmentation of antipsychotic treatment in older schizophrenia patients Int J Geriatr Psychiatry 16 12 2001 1163 1167
36. M.A. Friedman, J. Woodcock, and M.M. Lumpkin The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA 281 18 1999 1728 1734
37. S.R. Kay, L.A. Opler, and A. Fiszbein The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 2 1987 261 276
38. S. Madhusoodanan, R. Brenner, and S. Gupta Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies CNS Spectr 9 11 2004 862 867
39. R. Saitz, E.D. Helmuth, and S.E. Aromaa Web-based screening and brief intervention for the spectrum of alcohol problems Prev Med 39 5 2004 969 975
40. L. Herst, and G. Powell Is clozapine safe in the elderly? Aust N Z J Psychiatry 31 3 1997 411 417
41. L.D. Alphs, J.A. Lafferman, and L. Ross Fenfluramine treatment of negative symptoms in older schizophrenic inpatients Psychopharmacol Bull 25 1 1989 149 153
42. J.J. Weisbard, M. Pardo, and S. Pollack Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics Psychopharmacol Bull 33 1 1997 119 122
43. M. Sajatovic, D. Perez, and D. Brescan Olanzapine therapy in elderly patients with schizophrenia Psychopharmacol Bull 34 4 1998 819 823
44. S. Madhusoodanan, R. Brenner, and P. Suresh Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study Ann Clin Psychiatry 12 1 2000 11 18
45. S. Madhusoodanan, R. Brenner, and A. Alcantra Clinical experience with quetiapine in elderly patients with psychotic disorders J Geriatr Psychiatry Neurol 13 1 2000 28 32
46. P.P. Yeung, P.N. Tariot, and L.S. Schneider Quetiapine for elderly patients with psychotic disorders Psychiatr Ann 30 3 2000 197 201
47. I. Berman, A. Merson, and C. Sison Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study Psychopharmacol Bull 32 1 1996 95 100
48. R.A. Lasser, C.A. Bossie, and Y. Zhu Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder Int J Geriatr Psychiatry 19 9 2004 898 905
49. R. Bullock, and S. Libretto Risperidone in the treatment of psychoses in the elderly: a case report series Eur Psychiatry 17 2 2002 96 103
50. G. Mohler Clinical trial of thiothixene (Navane) in elderly chronic schizophrenics Curr Ther Res Clin Exp 12 6 1970 377 386
51. K.N. Chengappa, R.W. Baker, and S.B. Kreinbrook Clozapine use in female geriatric patients with psychoses J Geriatr Psychiatry Neurol 8 1 1995 12 15
52. J.K. Pitner, J.E. Mintzer, and L.C. Pennypacker Efficacy and adverse effects of clozapine in four elderly psychotic patients J Clin Psychiatry 56 5 1995 180 185
53. C. Salzman, B. Vaccaro, and J. Lieff Clozapine in older patients with psychosis and behavioral disruption Am J Geriatr Psychiatry 3 1 1995 26 33
54. M. Sajatovic, L.F. Ramirez, and D. Garver Clozapine therapy for older veterans Psychiatr Serv 49 3 1998 340 344
55. Y. Barak, N. Wittenberg, and S. Naor Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy Compr Psychiatry 40 4 1999 320 325
56. A.F. Oberholzer, C. Hendriksen, and A.U. Monsch Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study Int Psychogeriatr 4 2 1992 187 195
57. M.M. Tsuang, L.M. Lu, and B.A. Stotsky Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study J Am Geriatr Soc 19 7 1971 593 600
58. K. Solomons, and O. Geiger Olanzapine use in the elderly: a retrospective analysis Can J Psychiatry 45 2 2000 151 155
59. S. Madhusoodanan, P. Suresh, and R. Brenner Experience with the atypical antipsychotics: risperidone and olanzapine in the elderly Ann Clin Psychiatry 11 3 1999 113 118
60. S. Verma, C.A. Orengo, and M.E. Kunik Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients Int J Geriatr Psychiatry 16 2 2001 223 227
61. D. McManus, L. Arvanitis, B. Kowalcyk for the Seroquel Trial 48 Study Group Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders J Clin Psychiatry 60 5 1999 292 298
62. P.N. Tariot, C. Salzman, and P.P. Yeung Long-term use of quetiapine in elderly patients with psychotic disorders Clin Ther 22 9 2000 1068 1084
63. G.E. Jaskiw, P.T. Thyrum, and M.A. Fuller Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders Clin Pharmacokinet 43 14 2004 1025 1035 [erratum appears in: Clin Pharmacokinet. 2004;43(15):1178]
64. M. Sajatovic, L.F. Ramirez, L. Vernon, and D. Brescan Outcome of risperidone therapy in elderly patients with chronic psychosis Int J Psychiatry Med 26 3 1996 309 317
65. D.V. Jeste, J.P. Lacro, and A. Bailey Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients J Am Geriatr Soc 47 6 1999 716 719
66. S.J. Kiraly, R.E. Gibson, and R.J. Ancill Risperidone: treatment response in adult and geriatric patients Int J Psychiatry Med 28 2 1998 255 263
67. Y. Barak No weight gain among elderly schizophrenia patients after 1 year of risperidone treatment J Clin Psychiatry 63 2 2002 117 119
68. R. Stryjer, R.D. Strous, and F. Bar Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia Clin Neuropharmacol 26 1 2003 12 17
69. E. Mendelsohn, M. Rosenthal, and Y. Bohiri Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living Int Clin Psychopharmacol 19 6 2004 319 324
70. T. Bodenheimer Uneasy alliance: clinical investigators and the pharmaceutical industry N Engl J Med 342 20 2000 1539 1544
71. E. Granholm, J.R. McQuaid, and F.S. McClure A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia Schizophr Res 53 1-2 2002 167 169
72. E. Granholm, J.R. McQuaid, and F.S. McClure A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia Am J Psychiatry 162 3 2005 520 529
73. T.L. Patterson, C. McKibbin, and M. Taylor Functional adaptation skills training (FAST): a pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders Am J Geriatr Psychiatry 11 1 2003 17 23
74. S.J. Bartels, B. Forester, and K.T. Mueser Enhanced skills training and health care management for older persons with severe mental illness Community Ment Health J 40 1 2004 75 90
75. J.R. McQuaid, E. Granholm, and F.S. McClure Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia J Psychother Pract Res 9 3 2000 149 156
76. Pratt SI, Forester B, Bartels S. Integrating psychosocial rehabilitation and health care for older adults with SMI: from pilot study to randomized controlled trial. Paper presented at the 16th Annual Meeting of the American Association for Geriatric Psychiatry. Honolulu (HI), March 1-4, 2003.
77. D. Weintraub, and I. Katz Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety Psychiatr Clin North Am 28 4 2005 941 983
78. G.S. Alexopoulos, J. Streim, and D. Carpenter Using antipsychotic agents in older patients J Clin Psychiatry 65 Suppl 2004 S25 S99 [discussion: 100-2; quiz: 103-4]
79. J. Rosack FDA to require diabetes warning on antipsychotics Psychiatr News 38 20 2003 1-a-27
80. FDA's proposed diabetes warning Psychiatr News 38 20 2003 26
81. Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 2 2004 596 601
82. J.M. Alvir, J.A. Lieberman, and A.Z. Safferman Clozapine-induced agranulocytosis: incidence and risk factors in the United States N Engl J Med 329 3 1993 162 167
83. US Food and Drug Administration. FDA public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. April 11, 2005. Available at: http://www.fda.gov/cder/drug/advisory/antipsychotics.htm. Accessed May 28, 2005.
84. B.M. Kuehn FDA warns antipsychotic drugs may be risky for elderly JAMA 293 20 2005 2462